Background Renal clear cell carcinoma （RCCC） is the most common malignant renal tumor. It is highly malignant, does not cause clinical symptoms in its early stages, and cannot be diagnosed using conventional ultraso...Background Renal clear cell carcinoma （RCCC） is the most common malignant renal tumor. It is highly malignant, does not cause clinical symptoms in its early stages, and cannot be diagnosed using conventional ultrasound. This study was aimed to investigate the contrast-enhanced ultrasound （CEUS） mode and characteristics of the time-intensity curve for RCCC and its pathological basis. Methods Forty-two patients with pathologically diagnosed RCCC underwent CEUS examination before surgery. The patients＇ kidneys were visualized after injection of contrast agents using the Technos MPX DU8. We analyzed the CEUS mode, time-intensity curve, and pathological findings. Results The detection rate of RCCC with conventional ultrasound was about 71%, while the rate using CEUS was 100%. Larger tumors （33 cases） showed non-uniform enhancement with defective filling. CEUS modes were divided into 4 types： type Ⅰ, ＂quick in and out＂ （26.19%, 11/42）; type Ⅱ, ＂quick in and slow out＂ （40.48%, 17/42）; type Ⅲ, ＂Simultaneous in and out＂ （16.67%, 7/42）; and type Ⅳ ＂slow in and out＂ （16.67%, 7/42）. All types had a close correlation to the pathological basis. Time-intensity curve of CEUS consisted of 3 phases, the perfusion phase, regression phase, and lag phase. Cases of types Ⅰ and Ⅲ only had a perfusion and regression phase, those of type Ⅱ and Ⅳ had a perfusion phase, regression phase, and lag phase. Quantitative analysis of the time-intensity curve showed that the time-to-peak （FTP） of the lesions was shorter than that of normal renal parenchyma （P 〈0.0001）, the mean value of the up slope rate of the absolute value of lesions was higher than that of the ipsilateral normal renal parenchyma （P 〈0.0001）, and that the mean value of descent slope rate of the absolute value of lesions was lower than that of the ipsilateral normal renal parenchyma （P 〈0.0001）. Conclusions CEUS is useful in detecting small vessels in tumors. Although there are several differen展开更多
High mobility group box 1 (HMGB1) is a nuclear protein that can bind to DNA and act as a co-factor for gene transcription. When released into extracellular fluid, it plays a proinflammatory role by acting as a damage-...High mobility group box 1 (HMGB1) is a nuclear protein that can bind to DNA and act as a co-factor for gene transcription. When released into extracellular fluid, it plays a proinflammatory role by acting as a damage-associated molecular pattern molecule (DAMP) (also known as an alarmin) to initiate innate immune responses by activating multiple cell surface receptors such as the receptor for advanced glycation end-products (RAGE) and toll-like receptors (TLRs), TLR2, TLR4 or TLR9. This proinflammatory role is now considered to be important in the pathogenesis of a wide range of kidney diseases whether they result from hemodynamic changes, renal tubular epithelial cell apoptosis, kidney tissue fibrosis or inflammation. This review summarizes our current understanding of the role of HMGB1 in kidney diseases and how the HMGB1-mediated signaling pathway may constitute a new strategy for the treatment of kidney diseases. (C) 2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.展开更多
文摘Background Renal clear cell carcinoma （RCCC） is the most common malignant renal tumor. It is highly malignant, does not cause clinical symptoms in its early stages, and cannot be diagnosed using conventional ultrasound. This study was aimed to investigate the contrast-enhanced ultrasound （CEUS） mode and characteristics of the time-intensity curve for RCCC and its pathological basis. Methods Forty-two patients with pathologically diagnosed RCCC underwent CEUS examination before surgery. The patients＇ kidneys were visualized after injection of contrast agents using the Technos MPX DU8. We analyzed the CEUS mode, time-intensity curve, and pathological findings. Results The detection rate of RCCC with conventional ultrasound was about 71%, while the rate using CEUS was 100%. Larger tumors （33 cases） showed non-uniform enhancement with defective filling. CEUS modes were divided into 4 types： type Ⅰ, ＂quick in and out＂ （26.19%, 11/42）; type Ⅱ, ＂quick in and slow out＂ （40.48%, 17/42）; type Ⅲ, ＂Simultaneous in and out＂ （16.67%, 7/42）; and type Ⅳ ＂slow in and out＂ （16.67%, 7/42）. All types had a close correlation to the pathological basis. Time-intensity curve of CEUS consisted of 3 phases, the perfusion phase, regression phase, and lag phase. Cases of types Ⅰ and Ⅲ only had a perfusion and regression phase, those of type Ⅱ and Ⅳ had a perfusion phase, regression phase, and lag phase. Quantitative analysis of the time-intensity curve showed that the time-to-peak （FTP） of the lesions was shorter than that of normal renal parenchyma （P 〈0.0001）, the mean value of the up slope rate of the absolute value of lesions was higher than that of the ipsilateral normal renal parenchyma （P 〈0.0001）, and that the mean value of descent slope rate of the absolute value of lesions was lower than that of the ipsilateral normal renal parenchyma （P 〈0.0001）. Conclusions CEUS is useful in detecting small vessels in tumors. Although there are several differen
基金funded by the New Xiangya Talent Project of the Third Xiangya Hospital of Central South University(No.20150218)Program for New Century Excellent Talents in University(NCET-13-0605)+1 种基金the National Natural Science Foundation of China(No.81102512)Hunan Provincial Natural Science Foundation of China(No.14JJ7001)
文摘High mobility group box 1 (HMGB1) is a nuclear protein that can bind to DNA and act as a co-factor for gene transcription. When released into extracellular fluid, it plays a proinflammatory role by acting as a damage-associated molecular pattern molecule (DAMP) (also known as an alarmin) to initiate innate immune responses by activating multiple cell surface receptors such as the receptor for advanced glycation end-products (RAGE) and toll-like receptors (TLRs), TLR2, TLR4 or TLR9. This proinflammatory role is now considered to be important in the pathogenesis of a wide range of kidney diseases whether they result from hemodynamic changes, renal tubular epithelial cell apoptosis, kidney tissue fibrosis or inflammation. This review summarizes our current understanding of the role of HMGB1 in kidney diseases and how the HMGB1-mediated signaling pathway may constitute a new strategy for the treatment of kidney diseases. (C) 2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
